Flagship Harbor Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Flagship Harbor Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-428	Closed	–	–	1219
2020 Q3	$0	Hold	428	–	–	﹤0.01%	2072
2020 Q2	$0	Hold	428	–	–	﹤0.01%	2094
2020 Q1	$1K	Hold	428	–	–	﹤0.01%	1768
2019 Q4	$2K	Hold	428	–	–	﹤0.01%	1725
2019 Q3	$1K	Hold	428	–	–	﹤0.01%	1765
2019 Q2	$2K	Hold	428	–	–	﹤0.01%	1690
2019 Q1	$2K	Hold	428	–	–	﹤0.01%	1680
2018 Q4	$2K	Sell	428 -344	-45%	-$2.79K	﹤0.01%	1647
2018 Q3	$8K	Hold	772	–	–	﹤0.01%	1522
2018 Q2	$9K	Buy	+772	New	+$7.9K	﹤0.01%	1421

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return